Avarofloxacin (JNJ-Q2) is a broad-spectrum fluoroquinolone antibacterial agent being developed for the treatment of acute bacterial skin and skin-structure infections and community-acquired pneumonia[1]. Avarofloxacin (JNJ-Q2) is an aminoethylidenylpiper
Molecular Weight:
419.42
Purity:
99.36
CAS Number:
[878592-87-1]
Formula:
C21H23F2N3O4
Target:
Antibiotic,Bacterial
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted